Non Alcoholic Steatohepatitis (NASH) is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver.
NASH is closely related to the triple epidemic of obesity, pre-diabetes, and diabetes. If you are living with NASH you may qualify for a clinical research study.
ClinicalTrials.gov Study Details
Liver-biopsy Proven NASH
A phase 2b randomized, double blind, placebo-controlled, multicenter study evaluating safety and efficacy of EDP-305 in subjects with liver-biopsy proven non-alcoholic steatohepatitis (NASH) (ARGON-2)
Encore Borland Groover Clinical Research
Fleming Island Center for Clinical Research
Clinical Research Location 1679 Eagle Harbor Parkway Suite D Fleming Island FL 32003 postal
Contact Research: 9046210390
Research Email: MHerman@EncoreDocs.comINTERNET